Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Oncology|January 26, 2002
Significance of genetic variation at the glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase 1 detoxification genes in breast cancer developmentNava Siegelmann-Danieli, Kenneth H BuetowEuropean Journal of Internal Medicine|January 22, 2008
Orbital metastasis as the presenting symptom of extensive stage small cell lung cancerMichelle Henning, Qiyue Hu, Nava Siegelmann-DanieliHarefuah|February 14, 2007
[Molecular portrait of breast cancer with sub-classification of breast tumor]Nava Siegelmann-Danieli, Moshe E Stein, Natalio WallachPlos One|May 26, 2010
Dynamic computational model suggests that cellular citizenship is fundamental for selective tumor apoptosisMegan Olsen, Nava Siegelmann-Danieli, Hava T SiegelmannHarefuah|April 25, 2022
[PERSONALIZED MEDICINE IN ONCOLOGY REQUIRES TEAMWORK BETWEEN MEDICAL ONCOLOGISTS AND MOLECULAR PATHOLOGISTS]Nava Siegelmann-Danieli, Shimrat Mamrut, Einav Yehuda-Shnaidman, et al.International Journal of Women'S Health|December 10, 2021
Hormone-Replacement Therapy and Its Association with Breast Cancer Subtypes: A Large Retrospective Cohort StudyVered Rosenberg, Avital Bareket-Samish, Gabriel Chodick, et al.Cancer Epidemiology|December 18, 2010
Trends in breast cancer incidence associated with reductions in the use of hormone replacement therapyBarbara G Silverman, Nava Siegelmann-Danieli, Rony Braunstein, et al.Harefuah|December 13, 2002
[Hormone replacement therapy in breast cancer survivors: the Israeli Society for Clinical Oncology and Radiotherapy policy letter]Nava Siegelmann-Danieli, Ilan Ron, Bella Kaufman, et al.Tumori|March 10, 2010
Mitomycin C and vinblastine: an active regimen in previously treated breast cancer patientsInna Ospovat, Nava Siegelmann-Danieli, Tal Grenader, et al.Cancer Causes & Control : CCC|April 23, 2017
Primary prevention and screening practices among long-term breast cancer survivorsLori Mandelzweig, Angela Chetrit, Tova Amitai, et al.Pageof 5